Cite

HARVARD Citation

    Farraye, F. et al. (n.d.). P388 Analysis of the impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis programme. Journal of Crohn's and colitis. pp. S301-S302. [Online]. 
  
Back to record